Future perspectives of prostate cancer therapy We summarize several recent laboratory advances to tackle the problem of tumor-stroma-immune cell microenvironment interaction with the hope of developing and advancing new concepts and therapeutic strategies for prostate cancer therapy ... M Gururajan,EM Pos...
1.Tai X, et al. Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity. J Drug Target. 2016 Sep 9:1-29. 2.Pal SK, et al. Critical appraisal of cabazitaxel in the management of advanced prostate cancer. Clin Interv...
We sought to better understand the relationship between a market's managed-care penetration and the dissemination of robotic prostatectomy.We used SEER-Medicare data from 2003 through 2007 to identify men 鈮 66 years of age treated with radical prostatectomy for prostate cancer. We categorized Health...